Phoenix Biotech Acquisition Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Phoenix Biotech Acquisition Corp
TickerCEROW
CIK #0001870404
CUSIP71902K113
SectorReal Estate & Construction - Blank Checks
Address2001 Market Street Suite 3400, Philadelphia, PA 19103
Source [EDGAR]
CIK Filing 2011 - 2025
[0001870404] 10-K
[0001870404] 10-Q
[0001870404] 3
[0001870404] 4
[0001870404] 8-K
[0001870404] D
[0001870404] SC 13D
[0001870404] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Armistice Capital LLC CERO Therapeutics Holdings Inc [2025-05-15] 0.0
Corey Lawrence CERO Therapeutics Holdings Inc [2024-12-13] 81945.7
Sloan Stuart M CERO Therapeutics Holdings Inc [2024-11-20] 6.7
YK BioVentures Opportunities GP I LLC CERO Therapeutics Holdings Inc [2024-11-14] 15.0
Atwood Brian G CERO Therapeutics Holdings Inc [2024-10-30] 13.3
Shaolin Capital Management LLC Phoenix Biotech Acquisition Corp [2023-02-14] 6.58
Phoenix Biotech Sponsor LLC Phoenix Biotech Acquisition Corp [2023-02-01] 78.2
Saba Capital Management LP Phoenix Biotech Acquisition Corp [2022-05-06] 5.2
Phoenix Biotech Sponsor LLC Phoenix Biotech Acquisition Corp [2022-02-08] 23.0
Highbridge Capital Management LLC Phoenix Biotech Acquisition Corp [2021-10-22] 5.64
Beryl Capital Management LLC Phoenix Biotech Acquisition Corp [2021-10-18] 6.7
Cantor Fitzgerald Securities Phoenix Biotech Acquisition Corp [2021-10-18] 4.6
Form 3/4/5 Filer 2011 - 2025
CERO Therapeutics Holdings Inc
Kucharchuk Andrew Albert
Laporte Kathleen
Byrnes Michael
Rolfe Lindsey
Patel Shami
Ehrlich Christopher B
Atwood Brian G
Pierce Kristen
YK Bioventures Opportunities Fund I, L.P.
Kossar Mitchell William
YK Bioventures Opportunities GP I, LLC
Yeung Gary Kahing
Sloan Stuart M
Carter Charles Ross
Corey Daniel
Rapaport Robyn
Loewy Caroline M
Kosacz Barbara
Geffken Daniel E.
Fisher Douglas Carl
Phoenix Biotech Sponsor LLC
Form 13F Holdings
Firm Period DFND Voting Shares
Cantor Fitzgerald L P [2025-06-30] DFND 0 441,048
Toronto Dominion Bank [2025-06-30] DFND 0 381,318
MMCAP International Inc. SPC [2025-06-30] SOLE 375,000 375,000
Saba Capital Management LP [2025-06-30] SOLE 295,913 295,913
Clear Street Derivatives LLC [2025-06-30] SOLE 268,129 268,129
Linden Advisors LP [2025-06-30] SOLE 233,888 249,999
Blue Owl Capital Holdings LP [2025-06-30] DFND 0 224,930
Clear Street LLC [2025-06-30] SOLE 193,824 193,824
Q Global Advisors, LLC [2025-06-30] DFND 170,785 170,785
Context Capital Management LLC [2025-06-30] SOLE 122,013 122,013
Millennium Management LLC [2025-06-30] SOLE 0 108,750
NexPoint Asset Management LP [2025-06-30] SOLE 108,741 108,741
Picton Mahoney Asset Management [2025-06-30] SOLE 75,000 75,000
Westchester Capital Management LLC [2025-06-30] OTR 0 68,958
TENOR CAPITAL MANAGEMENT Co., L.P. [2025-06-30] SOLE 50,000 50,000
Parallel Advisors LLC [2025-06-30] SOLE 0 50,000
Wolverine Asset Management LLC [2025-06-30] DFND 33,796 33,796
Whitebox Advisors LLC [2025-06-30] SOLE 0 23,250
Virtu Financial LLC [2025-06-30] DFND 20,474 20,474
Calamos Advisors LLC [2025-06-30] SOLE 12,500 12,500
Dupont Capital Management Corp [2025-06-30] SOLE 12,500 12,500
Silver Rock Financial LP [2025-06-30] SOLE 12,224 12,224
Fortress Financial Solutions LLC [2025-06-30] SOLE 10,000 10,000
Westchester Capital Management LLC [2025-06-30] SOLE 6,040 6,040
Ancora Advisors LLC [2025-06-30] SOLE 2,500 2,500
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com